Cargando…

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

Influenza virus infections remain a major and recurrent public health burden. The intrinsic ever-evolving nature of this virus, the suboptimal efficacy of current influenza inactivated vaccines, as well as the emergence of resistance against a limited antiviral arsenal, highlight the critical need f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pizzorno, Andrés, Terrier, Olivier, Nicolas de Lamballerie, Claire, Julien, Thomas, Padey, Blandine, Traversier, Aurélien, Roche, Magali, Hamelin, Marie-Eve, Rhéaume, Chantal, Croze, Séverine, Escuret, Vanessa, Poissy, Julien, Lina, Bruno, Legras-Lachuer, Catherine, Textoris, Julien, Boivin, Guy, Rosa-Calatrava, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361841/ https://www.ncbi.nlm.nih.gov/pubmed/30761132 http://dx.doi.org/10.3389/fimmu.2019.00060

Ejemplares similares

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2019)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2020)

Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development
por: Dubois, Julia, et al.
Publicado: (2019)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Avian Cell Line DuckCelt(®)-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac(®)
por: Chupin, Caroline, et al.
Publicado: (2021)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020)

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
por: Jonsdottir, Hulda R., et al.
Publicado: (2022)

Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
por: Pizzorno, Andrés, et al.
Publicado: (2018)

Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors
por: Roche, Magali, et al.
Publicado: (2015)

La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe
por: Poissy, J., et al.
Publicado: (2016)

Sequencing the Genome of Indian Flying Fox, Natural Reservoir of Nipah Virus, Using Hybrid Assembly and Conservative Secondary Scaffolding
por: Fouret, Julien, et al.
Publicado: (2020)

Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice
por: Lê, Vuong B., et al.
Publicado: (2019)

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes
por: Del Campo, Judith, et al.
Publicado: (2019)

Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication
por: Terrier, Olivier, et al.
Publicado: (2016)

Effect of In Vitro Syncytium Formation on the Severity of Human Metapneumovirus Disease in a Murine Model
por: Aerts, Laetitia, et al.
Publicado: (2015)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets
por: Turgeon, Nathalie, et al.
Publicado: (2019)

Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway
por: Terrier, Olivier, et al.
Publicado: (2011)

Immunity check should be performed for all patients with septic shock? Yes
por: Textoris, Julien
Publicado: (2020)

Explainable artificial intelligence modeling for corporate social responsibility and financial performance
por: Lachuer, Julien, et al.
Publicado: (2022)

Co-infection of the respiratory epithelium, scene of complex functional interactions between viral, bacterial, and human neuraminidases
por: Escuret, Vanessa, et al.
Publicado: (2023)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all
por: Textoris, Julien, et al.
Publicado: (2017)

Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
por: Aerts, Laetitia, et al.
Publicado: (2013)

Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Involvement of the Wnt pathway in BVDV cytopathogenic strain replication in primary bovine cells
por: La Polla, Rémi, et al.
Publicado: (2022)

Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
por: Josset, Laurence, et al.
Publicado: (2010)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

Two consecutive cases of mycotic aneurysms resulting from Whipple disease
por: Menier, Charles Antoine, et al.
Publicado: (2023)

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2
por: Ruffin, M., et al.
Publicado: (2021)

In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing
por: Hénaut, Mathilde, et al.
Publicado: (2023)

Engineering of Live Chimeric Vaccines against Human Metapneumovirus
por: Ogonczyk Makowska, Daniela, et al.
Publicado: (2020)

Progress and pitfalls of a year of drug repurposing screens against COVID-19()
por: Sourimant, Julien, et al.
Publicado: (2021)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs
por: Saim-Mamoun, Amel, et al.
Publicado: (2023)

What applications for plasma endocan measurement in intensive care? A clarification
por: Dubar, Victoria, et al.
Publicado: (2023)

Assessing the Functional Heterogeneity of Monocytes in Human Septic Shock: a Proof-of-Concept Microfluidic Assay of TNFα Secretion
por: Llitjos, Jean-François, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvkqqbrvjub3b9o1qlbm7hrmjv